231 related articles for article (PubMed ID: 14754889)
21. Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage.
Jeong JK; Moon MH; Lee YJ; Seol JW; Park SY
Int J Mol Med; 2012 Mar; 29(3):387-92. PubMed ID: 22179431
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions.
Naslavsky N; Shmeeda H; Friedlander G; Yanai A; Futerman AH; Barenholz Y; Taraboulos A
J Biol Chem; 1999 Jul; 274(30):20763-71. PubMed ID: 10409615
[TBL] [Abstract][Full Text] [Related]
23. Manipulation of PrPres production in scrapie-infected neuroblastoma cells.
Bate C; Langeveld J; Williams A
J Neurosci Methods; 2004 Sep; 138(1-2):217-23. PubMed ID: 15325130
[TBL] [Abstract][Full Text] [Related]
24. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
25. Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro.
Bate C; Rutherford S; Gravenor M; Reid S; Williams A
Neuroreport; 2002 Oct; 13(15):1933-8. PubMed ID: 12395095
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol esterification reduces the neurotoxicity of prions.
Bate C; Tayebi M; Williams A
Neuropharmacology; 2008 Jun; 54(8):1247-53. PubMed ID: 18448139
[TBL] [Abstract][Full Text] [Related]
27. Aggregation and fibrillization of prions in lipid membranes.
Kazlauskaite J; Pinheiro TJ
Biochem Soc Symp; 2005; (72):211-22. PubMed ID: 15649144
[TBL] [Abstract][Full Text] [Related]
28. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
29. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
30. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
31. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells.
Gomes MP; Millen TA; Ferreira PS; e Silva NL; Vieira TC; Almeida MS; Silva JL; Cordeiro Y
J Biol Chem; 2008 Jul; 283(28):19616-25. PubMed ID: 18456654
[TBL] [Abstract][Full Text] [Related]
32. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
33. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
[TBL] [Abstract][Full Text] [Related]
34. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
35. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
Allard EK; Grujic M; Fisone G; Kristensson K
Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
[TBL] [Abstract][Full Text] [Related]
36. Stress-protective signalling of prion protein is corrupted by scrapie prions.
Rambold AS; Müller V; Ron U; Ben-Tal N; Winklhofer KF; Tatzelt J
EMBO J; 2008 Jul; 27(14):1974-84. PubMed ID: 18566584
[TBL] [Abstract][Full Text] [Related]
37. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
38. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
[TBL] [Abstract][Full Text] [Related]
39. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
40. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z
J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
